Anticorps Polyclonal de lapin anti-CCL19/MIP-3 beta
CCL19/MIP-3 beta Polyclonal Antibody for WB, IF/ICC, FC (Intra), ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, IHC, IF/ICC, FC (Intra), ELISA
Conjugaison
Non conjugué
N° de cat : 13397-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules THP-1, |
| Résultats positifs en IF/ICC | cellules A549, |
| Résultats positifs en FC (Intra) | cellules A549 |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.40 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| IHC | See 4 publications below |
| IF | See 5 publications below |
Informations sur le produit
13397-1-AP cible CCL19/MIP-3 beta dans les applications de WB, IHC, IF/ICC, FC (Intra), ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Réactivité citée | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | CCL19/MIP-3 beta Protéine recombinante Ag4200 |
| Nom complet | chemokine (C-C motif) ligand 19 |
| Masse moléculaire calculée | 98 aa, 12 kDa |
| Poids moléculaire observé | 11 kDa |
| Numéro d’acquisition GenBank | BC027968 |
| Symbole du gène | CCL19/MIP-3 beta |
| Identification du gène (NCBI) | 6363 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
CCL19, also known as MIP-3β, is one of several CC cytokine genes clustered on the p-arm of chromosome 9. CCL19 may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs. It specifically binds to chemokine receptor CCR7.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for CCL19/MIP-3 beta antibody 13397-1-AP | Download protocol |
| IF protocol for CCL19/MIP-3 beta antibody 13397-1-AP | Download protocol |
| FC protocol for CCL19/MIP-3 beta antibody 13397-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Am J Respir Crit Care Med Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. | ||
Ann Rheum Dis Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin. | ||
Front Immunol The Impact of Immune Microenvironment on the Prognosis of Pancreatic Ductal Adenocarcinoma Based on Multi-Omics Analysis | ||
J Innate Immun The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent | ||
Front Physiol Potential biomarkers and immune cell infiltration involved in aortic valve calcification identified through integrated bioinformatics analysis | ||
Biomol Biomed Identifying key inflammatory genes in psoriasis via weighted gene co-expression network analysis: Potential targets for therapy |




